Up And Down The Ladder... Job Changes

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Tolera Therapeutics hired Ashleigh Palmer as ceo and president. Palmer, who will continue as president of Creative BioVentures, a strategic advisory firm, as a result of which he was ceo at Restoragen, Canfite Biopharma and Unigene Laboratories. Previously, he was vp of business development at Ohmeda. Aptuit hired Jonathan Goldman as ceo; Takeda Pharmaceutical hired Chris Weber as chief operating officer; Valeant Pharmaceuticals hired Ari Kellen as executive vp and company group chairman; Novartis Korea named Son Ju-bum as head of vaccines for its Korea cluster; Array BioPharma says Kevin Koch has resigned as president and chief scientific officer; Pfizer promoted Matt Meehan to senior manager of its political action committee; Glenmark named Philip Andrew Gioia as president, North America and the global API business; AstraZeneca hired Joanne Jerman as a director for its global...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs